Anti-VEGFC/ Flt4-L/ LMPH1D functional antibody

Anti-VEGFC/ Flt4-L/ LMPH1D functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to VEGFC/VEGFC products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T51425-Ab-1/ GM-Tg-hg-T51425-Ab-2Anti-Human VEGFC monoclonal antibodyHuman
GM-Tg-rg-T51425-Ab-1/ GM-Tg-rg-T51425-Ab-2Anti-Rat VEGFC monoclonal antibodyRat
GM-Tg-mg-T51425-Ab-1/ GM-Tg-mg-T51425-Ab-2Anti-Mouse VEGFC monoclonal antibodyMouse
GM-Tg-cynog-T51425-Ab-1/ GM-Tg-cynog-T51425-Ab-2Anti-Cynomolgus/ Rhesus macaque VEGFC monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T51425-Ab-1/ GM-Tg-felg-T51425-Ab-2Anti-Feline VEGFC monoclonal antibodyFeline
GM-Tg-cang-T51425-Ab-1/ GM-Tg-cang-T51425-Ab-2Anti-Canine VEGFC monoclonal antibodyCanine
GM-Tg-bovg-T51425-Ab-1/ GM-Tg-bovg-T51425-Ab-2Anti-Bovine VEGFC monoclonal antibodyBovine
GM-Tg-equg-T51425-Ab-1/ GM-Tg-equg-T51425-Ab-2Anti-Equine VEGFC monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T51425-Ab-1/ GM-Tg-hg-T51425-Ab-2; GM-Tg-rg-T51425-Ab-1/ GM-Tg-rg-T51425-Ab-2;
GM-Tg-mg-T51425-Ab-1/ GM-Tg-mg-T51425-Ab-2; GM-Tg-cynog-T51425-Ab-1/ GM-Tg-cynog-T51425-Ab-2;
GM-Tg-felg-T51425-Ab-1/ GM-Tg-felg-T51425-Ab-2; GM-Tg-cang-T51425-Ab-1/ GM-Tg-cang-T51425-Ab-2;
GM-Tg-bovg-T51425-Ab-1/ GM-Tg-bovg-T51425-Ab-2; GM-Tg-equg-T51425-Ab-1/ GM-Tg-equg-T51425-Ab-2
Products NameAnti-VEGFC monoclonal antibody
Formatmab
Target NameVEGFC
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-VEGFC benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T51425-Ag-1Recombinant multi-species VEGFC/ Flt4-L/ LMPH1D protein
    CytokineGM-Tg-g-T51425-Ag-1Vascular endothelial growth factor C (VEGFC) protein
    ORF Viral VectorvGMAP000194Human VEGFC Adenovirus particle
    ORF Viral VectorpGMAP000194Human VEGFC Adenovirus plasmid
    ORF Viral VectorpGMLPm001747mouse Vegfc Lentivirus plasmid
    ORF Viral VectorvGMLPm001747mouse Vegfc Lentivirus particle


    Target information

    Target IDGM-T51425
    Target NameVEGFC
    Gene ID7424,22341,114111,699502,482932,101085368,282122,100060890
    Gene Symbol and SynonymsFlt4-L,LMPH1D,LMPHM4,VEGF-C,VEGFC,VRP
    Uniprot AccessionP49767,O35757
    Uniprot Entry NameVEGFC_HUMAN,VEGFC_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target, Cytokine Target
    DiseaseBreast Cancer
    Gene EnsemblENSG00000150630
    Target ClassificationN/A

    The target: VEGFC, gene name: VEGFC, also named as Flt4-L, LMPH1D, VRP. The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family. The encoded protein promotes angiogenesis and endothelial cell growth, and can also affect the permeability of blood vessels. The proprotein is further cleaved into a fully processed form that can bind and activate VEGFR-2 and VEGFR-3 receptors. [provided by RefSeq, Apr 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.